AI, omics, and systems biology can now help scientists design targeted drugs for cardiovascular disease pathways once thought “untreatable.”
This is according to a new article published in Frontiers in Science, in which researchers say these tools could transform heart drug development and save lives but that global, equitable health policy leadership is urgently needed.
Join the article authors—Prof Masanori Aikawa, Prof Joseph Loscalzo, Dr Chiara Giannarelli, and Prof Jean-Luc Balligand—at our Frontiers Forum Deep Dive webinar on 17 November 2025, 16:00–17:30 CET, as they argue for a radical shift in how new cardiovascular medicines are discovered, developed, and tested—moving beyond one-size-fits-all drug therapies toward precision medicine.
The authors call for greater interdisciplinary and intersectoral collaboration, with an emphasis on data science, across the entire cardiovascular research and innovation pathway to tackle this leading cause of death.
At this Deep Dive event, hear our panel of experts discuss strategies to engage policymakers in securing the funding, resources, and regulatory frameworks needed to ensure that scientific advances benefit everyone—including those in low- and middle-income countries.
Precision cardiovascular medicine: shifting the innovation paradigm | Register
Frontiers Forum Deep Dive sessions bring researchers, policy experts, and innovators together from around the world, to discuss a specific area of transformational science published in Frontiers' flagship, multidisciplinary journal, Frontiers in Science, and explore next steps for the field.